Cryptosporidiosis in patients with AIDS

Correlates of disease and survival

Yukari C. Manabe, Douglas P. Clark, Richard D. Moore, Jeanne Ann Lumadue, Holly R. Dahlman, Peter C. Belitsos, Richard E. Chaisson, Cynthia L. Sears

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Although 10%-15% of patients with AIDS in the United States may acquire cryptosporidium infection, little data exist on clinical or histological characteristics that differentiate clinical outcomes. A case-control study of 83 HIV-positive adult patients with cryptosporidiosis was conducted, as was a histopathologic review of data on gastrointestinal biopsy specimens from 30 patients. Four clinical syndromes were identified: chronic diarrhea (36% of patients), choleralike disease (33%), transient diarrhea (15%), and relapsing illness (15%). A multivariate analysis of data for cases and controls revealed that acquiring cryptosporidiosis was associated with the presence of candidal esophagitis (odds ratio [OR], 2.53; P < .002) and Caucasian race (OR, 6.71; P = .0001) but not with sexual orientation. Cases had a significantly shorter duration of survival from the time of diagnosis than did controls (240 vs. 666 days, respectively; P = .0004), which was independent of sex, race, or injection drug use. Antiretroviral use was protective against disease (OR, 0.072; P = .0001). All four clinical syndromes were represented among the histological data. There was no statistically significant correlation between histological intensity of infection and clinical severity of illness.

Original languageEnglish (US)
Pages (from-to)536-542
Number of pages7
JournalClinical Infectious Diseases
Volume27
Issue number3
DOIs
StatePublished - Jan 1 1998

Fingerprint

Cryptosporidiosis
Acquired Immunodeficiency Syndrome
Survival
Odds Ratio
Diarrhea
Cryptosporidium
Esophagitis
Infection
Sexual Behavior
Case-Control Studies
Multivariate Analysis
HIV
Biopsy
Injections
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Manabe, Y. C., Clark, D. P., Moore, R. D., Lumadue, J. A., Dahlman, H. R., Belitsos, P. C., ... Sears, C. L. (1998). Cryptosporidiosis in patients with AIDS: Correlates of disease and survival. Clinical Infectious Diseases, 27(3), 536-542. https://doi.org/10.1086/514701
Manabe, Yukari C. ; Clark, Douglas P. ; Moore, Richard D. ; Lumadue, Jeanne Ann ; Dahlman, Holly R. ; Belitsos, Peter C. ; Chaisson, Richard E. ; Sears, Cynthia L. / Cryptosporidiosis in patients with AIDS : Correlates of disease and survival. In: Clinical Infectious Diseases. 1998 ; Vol. 27, No. 3. pp. 536-542.
@article{fa933a6d6ce14719834e1530fbd990f2,
title = "Cryptosporidiosis in patients with AIDS: Correlates of disease and survival",
abstract = "Although 10{\%}-15{\%} of patients with AIDS in the United States may acquire cryptosporidium infection, little data exist on clinical or histological characteristics that differentiate clinical outcomes. A case-control study of 83 HIV-positive adult patients with cryptosporidiosis was conducted, as was a histopathologic review of data on gastrointestinal biopsy specimens from 30 patients. Four clinical syndromes were identified: chronic diarrhea (36{\%} of patients), choleralike disease (33{\%}), transient diarrhea (15{\%}), and relapsing illness (15{\%}). A multivariate analysis of data for cases and controls revealed that acquiring cryptosporidiosis was associated with the presence of candidal esophagitis (odds ratio [OR], 2.53; P < .002) and Caucasian race (OR, 6.71; P = .0001) but not with sexual orientation. Cases had a significantly shorter duration of survival from the time of diagnosis than did controls (240 vs. 666 days, respectively; P = .0004), which was independent of sex, race, or injection drug use. Antiretroviral use was protective against disease (OR, 0.072; P = .0001). All four clinical syndromes were represented among the histological data. There was no statistically significant correlation between histological intensity of infection and clinical severity of illness.",
author = "Manabe, {Yukari C.} and Clark, {Douglas P.} and Moore, {Richard D.} and Lumadue, {Jeanne Ann} and Dahlman, {Holly R.} and Belitsos, {Peter C.} and Chaisson, {Richard E.} and Sears, {Cynthia L.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1086/514701",
language = "English (US)",
volume = "27",
pages = "536--542",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "3",

}

Manabe, YC, Clark, DP, Moore, RD, Lumadue, JA, Dahlman, HR, Belitsos, PC, Chaisson, RE & Sears, CL 1998, 'Cryptosporidiosis in patients with AIDS: Correlates of disease and survival', Clinical Infectious Diseases, vol. 27, no. 3, pp. 536-542. https://doi.org/10.1086/514701

Cryptosporidiosis in patients with AIDS : Correlates of disease and survival. / Manabe, Yukari C.; Clark, Douglas P.; Moore, Richard D.; Lumadue, Jeanne Ann; Dahlman, Holly R.; Belitsos, Peter C.; Chaisson, Richard E.; Sears, Cynthia L.

In: Clinical Infectious Diseases, Vol. 27, No. 3, 01.01.1998, p. 536-542.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cryptosporidiosis in patients with AIDS

T2 - Correlates of disease and survival

AU - Manabe, Yukari C.

AU - Clark, Douglas P.

AU - Moore, Richard D.

AU - Lumadue, Jeanne Ann

AU - Dahlman, Holly R.

AU - Belitsos, Peter C.

AU - Chaisson, Richard E.

AU - Sears, Cynthia L.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Although 10%-15% of patients with AIDS in the United States may acquire cryptosporidium infection, little data exist on clinical or histological characteristics that differentiate clinical outcomes. A case-control study of 83 HIV-positive adult patients with cryptosporidiosis was conducted, as was a histopathologic review of data on gastrointestinal biopsy specimens from 30 patients. Four clinical syndromes were identified: chronic diarrhea (36% of patients), choleralike disease (33%), transient diarrhea (15%), and relapsing illness (15%). A multivariate analysis of data for cases and controls revealed that acquiring cryptosporidiosis was associated with the presence of candidal esophagitis (odds ratio [OR], 2.53; P < .002) and Caucasian race (OR, 6.71; P = .0001) but not with sexual orientation. Cases had a significantly shorter duration of survival from the time of diagnosis than did controls (240 vs. 666 days, respectively; P = .0004), which was independent of sex, race, or injection drug use. Antiretroviral use was protective against disease (OR, 0.072; P = .0001). All four clinical syndromes were represented among the histological data. There was no statistically significant correlation between histological intensity of infection and clinical severity of illness.

AB - Although 10%-15% of patients with AIDS in the United States may acquire cryptosporidium infection, little data exist on clinical or histological characteristics that differentiate clinical outcomes. A case-control study of 83 HIV-positive adult patients with cryptosporidiosis was conducted, as was a histopathologic review of data on gastrointestinal biopsy specimens from 30 patients. Four clinical syndromes were identified: chronic diarrhea (36% of patients), choleralike disease (33%), transient diarrhea (15%), and relapsing illness (15%). A multivariate analysis of data for cases and controls revealed that acquiring cryptosporidiosis was associated with the presence of candidal esophagitis (odds ratio [OR], 2.53; P < .002) and Caucasian race (OR, 6.71; P = .0001) but not with sexual orientation. Cases had a significantly shorter duration of survival from the time of diagnosis than did controls (240 vs. 666 days, respectively; P = .0004), which was independent of sex, race, or injection drug use. Antiretroviral use was protective against disease (OR, 0.072; P = .0001). All four clinical syndromes were represented among the histological data. There was no statistically significant correlation between histological intensity of infection and clinical severity of illness.

UR - http://www.scopus.com/inward/record.url?scp=0031666793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031666793&partnerID=8YFLogxK

U2 - 10.1086/514701

DO - 10.1086/514701

M3 - Article

VL - 27

SP - 536

EP - 542

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 3

ER -